Oncology

Latest News

Melanoma & Skin Cancer Awareness Month | Image credit: Waseem Ali Khan - stock.adobe.com
5 Things You Should Know About Skin Cancer

May 2nd 2025

As skin cancer rates continue to rise, here are 5 key facts every health care professional should know to improve prevention, early detection, and patient outcomes.

stethoscopewithcompass | Image Credit: © Talaj-stock.adobe.com
Patient Navigation Is Nonnegotiable in Cancer Care

May 1st 2025

Liver cancer - Sebastian Kaulitzki - stock.adobe.com.jpg
Elevated HLA-G Seen in HCC Driven by Viral Infections, Fatty Liver

May 1st 2025

Doctor carrying documentation for patient care | image credit: Kanisorn - stock.adobe.com.jpeg
NCODA Outlines New Patient-Centered Oncology Distribution Models

May 1st 2025

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com
New Developments Warrant Rethinking HCC Transplant Criteria

April 29th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Site Logo
May 4th 2022

Rising Use of Surveillance Colonoscopy and Potential Impacts

Megan A. Adams, MD, JD, MSc Joel H. Rubenstein, MD, MSc Rob Holleman, MPH Rachel Lipson, MA Mandi L. Klamerus, MPH Shannon Zoulek, MD Sameer D. Saini, MD, MS
The proportion of colonoscopies performed for postpolypectomy surveillance has increased significantly, particularly among older patients with limited life expectancy, raising concern for possible overuse.
Site Logo
May 3rd 2022

Patterns of Opioid Use in Commercially Insured Patients With Cancer

Tham Thi Le, PhD, MPH Sean P. Fleming, MSW Linda Simoni-Wastila, PhD, MSPH
Among the fewer than half of patients with cancer who received opioid fills, a relatively small proportion (2.5%) had potentially problematic opioid use.
Newspapers
May 2nd 2022

What We're Reading: Decision Date on COVID-19 Vaccine for Young Children; AAP Guidance Review; FDA Rebuffs 2 Cancer Therapies

AJMC Staff
The FDA sets a tentative date for a decision on authorizing a COVID-19 vaccine in children under 5 years of age; the American Academy of Pediatrics will review all of its guidance for unproven race-based recommendations contributing to health disparities; the FDA rejects 2 China-tested cancer treatments.
money being allocated for a number of health realted causes
May 2nd 2022

Crowdfunding for Cancer: What Financial Toxicity Among Young Adults Says About the US Health Care System

Skylar Jeremias
Although crowdfunding can be a financial lifeline for young adult patients with serious medical conditions, the nuances regarding the need for and the long-term impact of crowdfunding exposes a facet of the US health care system that must be addressed.
Elaine Goodman, MD, MBA
April 26th 2022

Dr Elaine Goodman: Why Health Care Systems Should Consider the Patient Perspective

Hayden E. Klein
When clinicians consider the patient journey from beginning to end, they begin to understand how difficult it is for patients to access care, said Elaine Goodman, MD, MBA, clinical lead for population health management, Mass General Brigham.
AON Partners With Annexus Health to Help Patients Gain Financial Assistance
April 19th 2022

AON Partners With Annexus Health to Help Patients Gain Financial Assistance

AJMC Staff
The CEO of the American Oncology Network cited the growing need for financial assistance in announcing the partnership.
We Need a Cancer Patient Bill of Rights
April 18th 2022

We Need a Cancer Patient Bill of Rights

Joseph Alvarnas, MD
From the editor-in-chief of Evidence-Based Oncology.
Conference Coverage: ACCC 2022 AMCCBS
April 14th 2022

Conference Coverage: ACCC 2022 AMCCBS

Mary Caffrey
Coverage from the Association of Community Cancer Centers 2022 Annual Meeting and Cancer Center Business Summit, held in Washington, DC, March 2-4.
Conference Coverage: Cholangiocarcinoma Foundation 2022
April 14th 2022

Conference Coverage: Cholangiocarcinoma Foundation 2022

Mary Caffrey
Coverage from the 2022 annual meeting of the Cholangiocarcinoma Foundation, which met February 23-25 in Salt Lake City, Utah.
What’s Next for Real-World Evidence in Oncology?
April 13th 2022

What’s Next for Real-World Evidence in Oncology?

Michael Vasconcelles, MD Brad Jordan, PhD
Recent steps by FDA to promote the use of real-world evidence are to be commended, but the future demands a broader vision that makes greater use of growing sources of health care information.
Sharpless Steps Down as NCI Director
April 4th 2022

Sharpless Steps Down as NCI Director

Mary Caffrey
Norman E. “Ned” Sharpless, MD, is departing shortly after the launch of Cancer Moonshot 2.0, an initiative that aims to reduce the cancer death rate by at least half over the next 25 years while improving the experience for all those affected by cancer.
Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action
March 15th 2022

Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action

Kashyap Patel, MD Hirangi Mukhi, BS Anjana Patel, BSc Niyati Nathwani, MD Dhwani Mehta, MS Jennifer Sherak, MBA Natasha Clinton, MSN, APRN, AOCNP Holly Pisarik, JD Benjamin Brown, BS Sara Rogers, PharmD Mary Kruczynski Nicolas Ferreyros, BA Ted Okon, MBA
No One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.
Patel et al, Appendix B
March 15th 2022

Patel et al, Appendix B

COA 2022 Preview: Leaders Excited About Seeing Colleagues in Person
March 14th 2022

COA 2022 Preview: Leaders Excited About Seeing Colleagues in Person

Mary Caffrey
The first in-person Community Oncology Alliance (COA) meeting in 2 years will feature sessions on practice management, health disparities, and more. A virtual option is available.
Site Logo
March 9th 2022

Oncology Alternative Payment Models: Lessons From Commercial Insurance

Elizabeth Shaughnessy, MA David C. Johnson, MD, MPH Aaron J. Lyss, MBA Ravi B. Parikh, MD, MPP Steven R. Peskin, MD, MBA, MACP Blase N. Polite, MD, MPP Julie A. Royalty Bhuvana Sagar, MD, MBA Erin Smith, JD Lindee Goh, PhD
Developing alternative payment models for commercial populations in specialties such as oncology is rife with practical challenges. Leading payers and practices share lessons to date.
Purva Rawal, PhD
February 21st 2022

CMS Official Cites OCM as Example of Biosimilar Success

Mary Caffrey
Purva Rawal, PhD, senior advisor and chief strategy officer, Center for Medicare and Medicaid Innovation, addressed attendees at the Association for Accessible Medicines' Access! annual meeting, held in Orlando, Florida, February 15-16.
Joseph Alvarnas, MD
February 16th 2022

From the Editor-in-Chief: From the Earth to the Moon (and Back)

Joseph Alvarnas, MD
The president’s aim is a 50% reduction in age-adjusted cancer deaths by 2047. This goal seems audacious, but it is likely achievable.
DNA.
February 15th 2022

Tumor Mutational Burden May Help Predict Immunotherapy Response in Metastatic NSCLC

Matthew Gavidia
Response to immunotherapy and survival outcomes were found to be significantly associated with tumor mutational burden in patients with stage IV non-small cell lung cancer.
Emory’s Winship Joins AccessHope as Collaboration Partner
February 14th 2022

Emory’s Winship Joins AccessHope as Collaboration Partner

Mary Caffrey
AccessHope is a program that allows patients and community oncologists to tap into the expertise of City of Hope, often through electronic sharing of records so the patient does not have to travel.
SAP badge AJMC
February 14th 2022

From Our Partners: Schleicher, Dickson Take New Roles at Tennessee Oncology

Hayden E. Klein Mary Caffrey
The changes come as Tennessee Oncology must now plan for a gap between the Oncology Care Model and a future alternative payment model from CMS.
What We're Reading
February 2nd 2022

What We’re Reading: Cancer Moonshot Returns; New Omicron Subvariant; Drug Overdose Suicide Rates

AJMC Staff
President Biden announced he would bring back the Cancer Moonshot initiative that launched in the Obama administration; the World Health Organization said the Omicron subvariant, BA.2, appears to have the same severity as the original Omicron variant; cases of suicide by drug overdose increased in young people, older adults, and non-Hispanic Black women.
COA Survey: Practices Find OCM a Success; Some Added Services May Be at Risk
January 31st 2022

COA Survey: Practices Find OCM a Success; Some Added Services May Be at Risk

Mary Caffrey
The Oncology Care Model (OCM) is set to expire June 30, 2022. With no successor on the horizon, respondents to a recent survey by the Community Oncology Alliance (COA) say features such as dedicated navigators and weekend appointments could be reduced or lost if revenues that supported them are eliminated.
Site Logo
January 11th 2022

Management of TRK Fusion Cancer: Evaluating Targeted Therapies - Participating Faculty

Site Logo
January 11th 2022

Diagnosis and Management of TRK Fusion Cancer

Shivaani Kummar, MD, FACP Antoine Italiano, MD, PhD Marcia S. Brose, MD, PhD Josh J. Carlson, PhD, MPH Sean D. Sullivan, PhD, MSc, RPh Ulrik Lassen, MD, PhD Noah Federman, MD
Site Logo
January 11th 2022

Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer

Josh J. Carlson, PhD, MPH Antoine Italiano, MD, PhD Marcia S. Brose, MD, PhD Noah Federman, MD Ulrik Lassen, MD, PhD Shivaani Kummar, MD, FACP Sean D. Sullivan, PhD, MSc, RPh
Stephen Schleicher, MD, MBA
January 3rd 2022

Tennessee Oncology Names Dr Stephen Schleicher CMO, Dr Natalie Dickson CSO

Hayden E. Klein
Tennessee Oncology appointed Stephen Schleicher, MD, MBA, as Chief Medical Officer (CMO), with president Natalie Dickson, MD, being promoted from CMO to Chief Strategy Officer (CSO).
Burt Zweigenhaft, PhD, DLitt, Upstream Partners
December 20th 2021

CONFERENCE COVERAGE: Asembia 2021

Matthew Gavidia
Coverage from the Asembia 2021 Specialty Pharmacy Summit in Las Vegas.
PCOC Spotlight: There’s Been a Lot of Good for Patients With the OCM, Says US Oncology’s Neubauer
December 20th 2021

PCOC Spotlight: There’s Been a Lot of Good for Patients With the OCM, Says US Oncology’s Neubauer

Laura Joszt, MA
Marcus Neubauer, MD, chief medical officer, The US Oncology Network. He is an expert in precision medicine, value-based care, and clinical pathways.
PCOC Spotlight: How Community Oncology Is a Low-Cost, High-Quality Provider
December 20th 2021

PCOC Spotlight: How Community Oncology Is a Low-Cost, High-Quality Provider

Laura Joszt, MA
Jeffrey Patton, MD, is the CEO of OneOncology, a national partnership of independent community oncologists based in Nashville, Tennessee. He is also executive chairman of the board, Tennessee Oncology, and a member of the board, Community Oncology Alliance.
In Oncology, Navigating PBMs Starts With Knowing What’s in the Contract
December 20th 2021

In Oncology, Navigating PBMs Starts With Knowing What’s in the Contract

Mary Caffrey
Vertical integration of payers and pharmacy benefit managers (PBMs) took flight with the mergers of Aetna and CVS Health and of Cigna and ExpressScripts. Panelists at Patient-Centered Oncology Care® said the shift has filtered down to affect access at the practice level.
<1
...
111213141516171819
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo